Literature DB >> 25683509

Subcellular distribution of the prion protein in sickness and in health.

Susan F Godsave1, Peter J Peters2, Holger Wille3.   

Abstract

The cellular prion protein (PrP(C)) is an ubiquitously expressed glycoprotein that is most abundant in the central nervous system. It is thought to play a role in many cellular processes, including neuroprotection, but may also contribute to Alzheimer's disease and some cancers. However, it is best known for its central role in the prion diseases, such as Creutzfeldt-Jakob disease (CJD), bovine spongiform encephalopathy (BSE), and scrapie. These protein misfolding diseases can be sporadic, acquired, or genetic and are caused by refolding of endogenous PrP(C) into a beta sheet-rich, pathogenic form, PrP(Sc). Once prions are present in the central nervous system, they increase and spread during a long incubation period that is followed by a relatively short clinical disease phase, ending in death. PrP molecules can be broadly categorized as either 'good' (cellular) PrP(C) or 'bad' (scrapie prion-type) PrP(Sc), but both populations are heterogeneous and different forms of PrP(C) may influence various cellular activities. Both PrP(C) and PrP(Sc) are localized predominantly at the cell surface, with the C-terminus attached to the plasma membrane via a glycosyl-phosphatidylinositol (GPI) anchor and both can exist in cleaved forms. PrP(C) also has cytosolic and transmembrane forms, and PrP(Sc) is known to exist in a variety of conformations and aggregation states. Here, we discuss the roles of different PrP isoforms in sickness and in health, and show the subcellular distributions of several forms of PrP that are particularly relevant for PrP(C) to PrP(Sc) conversion and prion-induced pathology in the hippocampus.
Copyright © 2015 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Cancer; Neurodegeneration; Neuroprotection; PrP(C); PrP(Sc); Prion; Protein misfolding

Mesh:

Substances:

Year:  2015        PMID: 25683509     DOI: 10.1016/j.virusres.2015.02.004

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  6 in total

1.  Cellular prion protein (PrPC) in the development of Merlin-deficient tumours.

Authors:  L Provenzano; Y Ryan; D A Hilton; J Lyons-Rimmer; F Dave; E A Maze; C L Adams; R Rigby-Jones; S Ammoun; C O Hanemann
Journal:  Oncogene       Date:  2017-07-10       Impact factor: 9.867

Review 2.  Proteomic analysis of fatty-acylated proteins.

Authors:  Tao Peng; Emmanuelle Thinon; Howard C Hang
Journal:  Curr Opin Chem Biol       Date:  2015-12-02       Impact factor: 8.822

3.  Transgenic Overexpression of the Disordered Prion Protein N1 Fragment in Mice Does Not Protect Against Neurodegenerative Diseases Due to Impaired ER Translocation.

Authors:  Behnam Mohammadi; Luise Linsenmeier; Mohsin Shafiq; Berta Puig; Giovanna Galliciotti; Camilla Giudici; Michael Willem; Thomas Eden; Friedrich Koch-Nolte; Yu-Hsuan Lin; Jörg Tatzelt; Markus Glatzel; Hermann C Altmeppen
Journal:  Mol Neurobiol       Date:  2020-05-04       Impact factor: 5.590

4.  Rabbit PrP Is Partially Resistant to in vitro Aggregation Induced by Different Biological Cofactors.

Authors:  Juliana N Angelli; Yulli M Passos; Julyana M A Brito; Jerson L Silva; Yraima Cordeiro; Tuane C R G Vieira
Journal:  Front Neurosci       Date:  2021-06-18       Impact factor: 4.677

5.  Membrane-enriched proteome changes and prion protein expression during neural differentiation and in neuroblastoma cells.

Authors:  J A Macedo; D Schrama; I Duarte; E Tavares; J Renaut; M E Futschik; P M Rodrigues; E P Melo
Journal:  BMC Genomics       Date:  2017-04-22       Impact factor: 3.969

Review 6.  A New Take on Prion Protein Dynamics in Cellular Trafficking.

Authors:  Rodrigo Nunes Alves; Rebeca Piatniczka Iglesia; Mariana Brandão Prado; Maria Isabel Melo Escobar; Jacqueline Marcia Boccacino; Camila Felix de Lima Fernandes; Bárbara Paranhos Coelho; Ailine Cibele Fortes; Marilene Hohmuth Lopes
Journal:  Int J Mol Sci       Date:  2020-10-20       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.